{
    "root": "64a65366-8577-48f2-9f8e-0332f126d3c1",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Gabapentin",
    "value": "20250301",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "Gabapentin Capsules are indicated for: \n                  \n                     \n                        •Management of postherpetic neuralgia in adults\n                     \n                        •Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications": "• Postherpetic Neuralgia (2.1) • Dose can be titrated up as needed to a dose of 1,800 mg/day • Day 1: Single 300 mg dose • Day 2: 600 mg/day (i.e., 300 mg two times a day) • Day 3: 900 mg/day (i.e., 300 mg three times a day) • Epilepsy with Partial Onset Seizures (2.2) • Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily • Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days • Dose should be adjusted in patients with reduced renal function (2.3, 2.4)",
    "warningsAndPrecautions": "Gabapentin Capsules, USP are available containing 300 mg of gabapentin, USP, supplied as follows:    \n                  300 mg capsules:\n                  Size '1' Hard gelatin capsules with yellow opaque cap and yellow opaque body, imprinted \"300 mg\" in blue ink on cap and \"235\" in blue ink on body, filled with white to off-white powder.\n                  Capsules are supplied in bottles of:\n                  Bottles of 90 Capsules                                                          NDC 82804-206-90\n                  \n                     Storage\n                  \n                  Store at 20°C to 25°C (68°F to 77°F); [see USP Controlled Room Temperature].",
    "adverseReactions": "Gabapentin capsules are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}